期刊文献+

唐氏筛查单项血清学指标异常对疾病的预测价值分析 被引量:2

Predictive value of single serological index abnormality in Down’s screening for the disease
下载PDF
导出
摘要 目的探讨早期唐氏筛查单项血清学指标异常对染色体异常疾病的预测价值。方法回顾分析2016年1月至2019年8月在东莞市人民医院行早期唐氏筛查共15034例的妊娠结果及产前诊断结果,根据唐筛结果将研究对象分为三组:唐氏筛查高风险组、唐氏筛查低风险+单项指标异常组、唐氏筛查低风险+单项指标正常组,分析比较三组间染色体病异常发生率的差异。结果唐氏筛查高风险组432例,确诊染色体异常10例(2.3%)。唐氏筛查低风险+单项指标异常组1081例,其中单纯游离β-人绒毛膜促性腺激素异常847例,确诊染色体异常1例(0.12%);单纯妊娠相关蛋白降低234例,确诊染色体异常1例(0.43%)。唐氏筛查低风险+单项指标正常组5057例,产前及产后随访确诊染色体异常2例(0.04%)。比较三组染色体病的发生率,结果提示唐氏筛查高风险组显著高于单项指标均正常的低风险组(χ^2=94.452,P<0.001),对于唐氏筛查低风险病例,单项指标异常的发生率与单项指标正常组差别无统计学意义(χ^2=2.894,P>0.05)。结论早期唐氏筛查低风险,单项血清学指标异常不建议作为产前诊断的指征。 Objective To analyze predictive value of single serological index abnormality in early Down's syndrome(DS)screening for chromosome abnormalities.Methods From January 2016to August 2019,a total of 15034pregnant women who received early DS screening in Dongguan Municipal People's Hospital were included in this study.The prenatal diagnosis results and pregnancy outcomes of the pregnant women were collected.According to DS screening results,the pregnant women were divided into three groups:high risk DS group,low risk DS with abnormal single serological index group and low risk DS with normal single serological index group.Incidence of chromosome abnormality was compared among the three groups.Results In the high risk DS group,432cases were determined as high risk DS,and 10cases(2.3%)were diagnosed as chromosome abnormalities.Among 1081cases in the low risk DS with single serological index group,847cases had abnormal freeβ-human chorionic gonadotropin(fβ-HCG)and 1case(0.12%)was diagnosed as chromosome abnormality,234cases had lowered single pregnancy associated plasma protein(PAPP-A)and 1case of chromosome abnormality was confirmed(0.43%).In the low risk DS with normal single serological index group,5057 cases presented low risk DS and normal single serological index,and 2cases of chromosome abnormality(0.04%)were confirmed in prenatal and postnatal follow-up.The incidence of chromosome diseases in the three groups was compared,and the results indicated that the incidence of chromosome disease in high risk DS group was significantly higher than that in the low risk DS with all serological indexes normal group(χ^2=94.452,P<0.001).For those low risk DS cases,in the incidence of chromosome disease there was no significant difference between the low risk DS with single serological index abnormal group and the low risk DS with single serological index normal group(χ^2=2.894,P>0.05).Conclusion At the first trimester,abnormality in serum biochemistry marker combined with low risk DS screening result shouldn't be considered as prenatal diagnosis indicator of DS.
作者 吴少敏 郭锦添 杨昕 唐莉 李秀兰 李婵 WU Shaomin;GUO Jintian;YANG Xin;TANG Li;LI Xiulan;LI Chan(Prenatal Diagnosis Center,Dongguan Municipal People's Hospital,Guangdong Dongguan 523000,China;Department of Clinical Laboratory,Dongguan Municipal People's Hospital,Guangdong Dongguan 523000,China;Prenatal Diagnosis Center,Guangzhou Women and Children's Medical Center,Guangdong Guangzhou 510623,China)
出处 《中国妇幼健康研究》 2020年第3期338-342,共5页 Chinese Journal of Woman and Child Health Research
关键词 唐氏血清学异常 游离β-人绒毛膜促性腺激素(fβ-HCG) 妊娠相关蛋白A(PAPP-A) 唐氏筛查 低风险 Down's serological abnormality freeβ-human chorionic gonadotropin(fβ-HCG) pregnancy associated plasma protein A(PAPP-A) Down's syndrome(DS)screening low risk
  • 相关文献

参考文献1

二级参考文献11

  • 1Canick J. Prenatal screening for trisomy 21: recent advances andguidelines[J]. CIin Chem Lab Med,2012,50:1003-1008.
  • 2Wald NJ, Rodeck C, Hackshaw AK, et al. SURUSS inperspective[J]. Br J Obstet Gynecol,2004,111: 521-531.
  • 3Malone FD, Canick JA, Ball RH,et al. First-trimester orsecond-trimester screening, or both, for Down’s syndrome[J].N EngI J Med,2005,353:2001-2011.
  • 4Hsu JJ,Shieh TT, Hsien FJ. Down syndrome screening in anAsian population using alph-feoprotein and free beta-hCG: Areport of the Taiwan Down Syndrome Screening Group [ J].Obstet Gynecol,1996,87:943-947.
  • 5Wapner R, Thorn E,Simpson JL, et al. First-trimesterscreening for trimmy 21 and 18[J]. N Engl J Med,2003,349:1405-1413.
  • 6BorreJl A. Promises and pitfalls of First-trimester sonographicmarkers in the detection of fetal aneuploidy[J]. Prenat Diagn,2009,29:62-68.
  • 7Borrell A,CasalsE, Fortuny A,et al. First-trimester screeningfor trisomy 21 combining biochemistry and ultrasound atindividually optimal gestational ages. An interventional study[J]. Prenat Diagn,2004,24:541-545.
  • 8Wright D, Spencer K,Kagan KK, et al. First-trimestercombined screening for trisomy 21 at 7-14 weeks’ gestation[J].Ultrasound Obstet Gynecol,2010,36:404-411.
  • 9刘启兰,胡娅莉,许争峰,王丽娟,孙庆,林宁,徐晓燕,刘艳,张建伟,童建孙,王兴海,何竞.江苏地区以人群为基础的唐氏综合征产前筛查和诊断研究[J].中华医学遗传学杂志,2010,27(3):340-342. 被引量:27
  • 10苗正友,刘霞,石统昆,葛嘉美,徐营.早、中孕期整合筛查唐氏综合征[J].中华医学杂志,2011,91(3):185-188. 被引量:16

共引文献24

同被引文献20

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部